Cipla reports net loss of Rs 61.79 crore in Q4

NEW DELHI: Pharma major Cipla on Thursday reported a consolidated net loss of Rs 61.79 crore for the quarter ended March 31, 2017. The company had reported net loss of Rs 92.83 crore in the same quarter last year.

Consolidated total revenue of the company increased 6.84 per cent to Rs 3,604.79 crore in the quarter under review, as against Rs 3,373.91 crore in the corresponding quarter.

Before closing 3.12 per cent down at Rs 504.10, shares of the company hit an intraday high and low of Rs 527 and Rs 497.40, respectively.

The board has also recommended dividend of Rs 2 per equity share of face value of Rs 2 per share for the year 2016-2017.

For the quarter ended March 31, 2017, Cipla started commercial production at its newly built formulation facility at Sikkim.